MedTrace Logo

Exome Sequencing Study in Cardiomyopathy to Identify New Risk Variants

NCT03754101 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2023-02-17

No results posted yet for this study

Summary

Genetic mutations has been proved to be associated wth the onset of cardiomyopathy. In the present study, we intend to identify new related variants or genes. From March, 2003 to November, 2017, patients diagnosed as cardiomyopathy were consecutively recruited, and their sampled were drawn from peripheral blood. Paired control group were also enrolled. The whole exome sequencing was used to find out the variants associated with the onset of cardiomyopathy and its prognosis.

Conditions

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Dao Wen Wang, Doctor · Tongji Hospital,Wuhan, Hubei, China, 430030

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-03
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754101 on ClinicalTrials.gov